Fast Track designation adds another regulatory tailwind, but clinical data in H2 2026 remains the true catalyst.
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
Healthcare
Page 3- Jun 29, 2026 · 07:00 · DHT · Routine +01
FDA approval on schedule validates $300M Viridian thesis; milestone payment is expected cash outflow for long-dated royalty stream.
DRI Healthcare Comments on Viridian's FDA Approval and Launch of Lumvoa(TM) (veligrotug-vvze)
- Jun 29, 2026 · 07:00 · CNVI · Routine +02
Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund
Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund
- Jun 26, 2026 · 20:59 · TELO · Admin03
Telo Genomics Announces Termination of Investor Relations Agreement
Telo Genomics Announces Termination of Investor Relations Agreement
- Jun 26, 2026 · 18:29 · APLI · Routine −04
Pre-revenue biotech burns through cash, relies on distant government milestones while facing immediate going-concern liquidity crunch.
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
- Jun 26, 2026 · 18:00 · ONCO · Routine +05
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
- Jun 26, 2026 · 17:00 · HLS · Admin06
HLS Therapeutics Reports Annual Meeting Results
HLS Therapeutics Reports Annual Meeting Results
- Jun 26, 2026 · 16:30 · VHI · Admin07
VitalHub Announces Results of Annual General Meeting of Shareholders
VitalHub Announces Results of Annual General Meeting of Shareholders
- Jun 26, 2026 · 16:15 · RVV · Routine −08
Cash-burning micro-cap biotech raises survival capital via dilutive private placement while pursuing repurposed drug for nerve agents and infectious diseases.
Revive Therapeutics Announces Proposed Private Placement
- Jun 26, 2026 · 16:11 · VIVI · Routine +09
Pioneering passive thermal protection for temperature-sensitive injectables amid aggressive global distribution expansion.
TempraMed Signs Non-Binding LOI with National Distributor in Saudi Arabia
- Jun 26, 2026 · 08:48 · HEM · Routine −10
Pre-revenue stem cell therapy developer advancing ACP-01 across ischemic indications while navigating severe liquidity constraints and ongoing dilutive financings.
Hemostemix Closes $360,000 First Tranche of Private Placement
- Jun 26, 2026 · 08:45 · MDNA · Routine −11
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
- Jun 26, 2026 · 08:30 · ONCO · Neutral12
Canadian preclinical-stage oncology company developing PNKP inhibitor ONC010 and AI-driven SynoGraph platform.
NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development
- Jun 26, 2026 · 08:30 · QNTM · Neutral13
Preclinical MS drug developer navigating FDA clinical hold while leveraging consumer supplement royalties.
NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis
- Jun 26, 2026 · 08:10 · VPT · Routine +14
AI cardiac imaging startup scaling niche partnerships while navigating a critical $55k cash balance and negative working capital.
Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease